As part of the ongoing Student/Postdoc-Run Speaker Series (SPRSS), and on behalf of the Neural Mechanisms of Psychedelic Drug Action Group, Dr. Deborah Mash from the University of Miami will give a talk titled "Ibogaine and Noribogaine: Mechanisms and Therapeutic Potential as Addiction Medicines.
Exploring the Future of VR and Digital Therapeutics
The Unparalleled Power of Ibogaine in Addiction Recovery With Tom Feegel, CEO of Beond
Breaking the Cycle of Addiction with Ibogaine
Ibogaine Receives Serious Media Attention
New research is stirring interest in ibogaine, which appears to help ease the agony of detox and prevent relapse. Used in other countries, it remains illegal in the U.S. Read…
In this episode, Joe interviews Deborah C. Mash, Ph.D.: neuroscientist; Professor Emerita of Neurology and Molecular and Cellular Pharmacology at the University of Miami Miller School of Medicine; and leading…
The Kentucky Opioid Abatement Advisory Commission held its first public hearing Monday, July 17, to discuss funding development of an opioid-use disorder treatment using the psychedelic drug ibogaine with some of the…
Deborah Mash is Professor of Neurology (Emeritus) and Molecular and Cellular Pharmacology at the University of Miami Miller School of Medicine. She has held uninterrupted NIH funding from the National…
If you or a loved one struggle with addiction, this is an episode you’re going to want to listen to. Many of our current pharmaceuticals stem from compounds discovered in…
